Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

11
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
11
Hepatitis01:25

Hepatitis

29
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
29
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

256
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
256
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

860
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
860
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

896
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
896
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

467
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
467

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gene expression of N-acetylglucosaminyltransferases III and V: a possible implication for liver regeneration.

Hepatology (Baltimore, Md.)·1995
Same author

Transfection of N-acetylglucosaminyltransferase III gene suppresses expression of hepatitis B virus in a human hepatoma cell line, HB611.

The Journal of biological chemistry·1995
Same author

[Operative removal of esophageal leiomyosarcoma: a case report].

Kyobu geka. The Japanese journal of thoracic surgery·1995
Same author

Differential chemotactic responses mediated by platelet-derived growth factor alpha- and beta-receptors.

Archives of biochemistry and biophysics·1995
Same author

Generators of somatosensory evoked potentials investigated by dipole tracing in the monkey.

Neuroscience·1995
Same author

[Fundus hypothermia at 29 degrees C prevents ischemic injury of the outer retina].

Nippon Ganka Gakkai zasshi·1995
Same journal

[Series : Physiclans and Disaster Medical Care ; Disaster action card at home medical care support].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·2019
Same journal

[The Cutting-edge of Medicine ; Hepcidin and renal anemia].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·2019
Same journal

[The Cutting-edge of Medicine : On Choosing Wisely campaign].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·2019
Same journal

[Usefulness of the treatment with corticosteroids and ciclosporin A for TAFRO syndrome].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·2019
Same journal

[Case Report ; A case of infection of Chlamydophila pneumoniae with ARDS].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·2019
Same journal

[Case Report A case of TAFRO syndrome successfully treated with intravenous cyclophosphamide therapy].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·2019
See all related articles

Related Experiment Video

Updated: Mar 24, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.8K

[Topics on type C chronic hepatitis]

N Hayashi

    Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine
    |October 29, 2000
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
    09:02

    Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

    Published on: June 5, 2020

    8.0K
    The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
    09:03

    The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

    Published on: February 3, 2012

    20.0K

    Related Experiment Videos

    Last Updated: Mar 24, 2026

    A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
    11:34

    A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

    Published on: May 10, 2022

    2.8K
    Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
    09:02

    Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

    Published on: June 5, 2020

    8.0K
    The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
    09:03

    The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

    Published on: February 3, 2012

    20.0K